- Rankings
- WIPR Insights
Patents
5 August 2025 A much-anticipated referral could upend the EPO’s controversial description amendment rule—and reshape European patent practice, as the Enlarged Board of Appeal prepares to weigh in on G 1/25. Marisa Woutersen reports.
Latest Features
Powerful patents lie behind the latest breakthroughs in sports—helping athletes train effectively, recover faster, and perform at their peak, explains Marisol Cardoso of Inventa.
Stephen Thaler’s next DABUS hearing at the UK High Court puts the inventorship test on trial. Thaler's counsel Ryan Abbott brings us up to date on the issues at the heart of this seminal case.
The first decisions under Coke Morgan Stewart’s controversial new factor reveal a different landscape for PTAB petitioners. Jessica Kaiser and Chris Marando of Perkins Coie explore the takeaways.
Now is a particularly good time for litigating patent disputes at the US International Trade Commission, write Eric Fues & Shivani Karthikeyan of Finnnegan.
Nigeria lacks AI-specific laws but hopes to become a leader in the space through a new regulatory framework, says Izuchukwu Chinedo of Inventa.
Iti Negi, a senior patent engineer at Mercedes-Benz, outlines how in-house teams can drive a more effective, inventor-friendly patent process.
Early-stage companies can face high costs and little reward if they don’t get their IP strategy right from the start, say Graham Phero and Paul Ainsworth of Sterne Kessler.
The latest patent data reveals where artificial intelligence is heading in the global tech race and explains how, and why, China is setting the pace, explains Ana Neves of Inventa.
More News
28 July 2025 Jennifer Che of Eagle IP explores key IP challenges in China and offers practical strategies to address them, covering topics such as AI, patent linkage and export controls in this LSPN session.
24 July 2025 US State Department has said it is engaging with Chinese officials to resolve situation | Federal employee failed to disclose he worked for US government, according to a report.
23 July 2025 Important cases on discretionary denials, prosecution laches, and trade secrets have been heard at the appellate court over June and July, explain Nathan Mammen and Cole Tipton of Snell & Wilmer.
23 July 2025 Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life sciences patents, as discussed at LSPN.
21 July 2025 This LSPN session features experts from EIP, The Broad Institute of MIT and Harvard, Pfizer, and an independent specialist discussing the protection of life science innovations involving big data, AI, and machine learning.
18 July 2025 The lawyer behind a landmark ruling that reshaped prior art rules reveals how the decision will impact patent-opposition proceedings, influence trade secrets, and why strong legal arguments should never be lost in a “sea of weaker ones”, finds Marisa Woutersen.
16 July 2025 After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking to Sarah Speight, the pair explain what makes a good IP strategy, why the UPC is largely “useless” without SPCs, and more.
Get up-to-date information on all our publications and events
World IP Review provides news and guidance on the challenges facing businesses and legal practitioners active in intellectual property.